Human growth hormone used off-label in 40% of pediatric patients -- JAMA.
HUMAN GROWTH HORMONE USED OFF-LABEL IN 40% OF PATIENTS, according to a survey of U.S. pediatric endocrinologists published in the Aug. 21 issue of the Journal of the American Medical Association. Leona Cuttler, MD, Case Western Reserve University, et al., analyzed surveys mailed to the 534 U.S. members of the Lawson Wilkins Pediatric Endocrine Society; 434 physicians responded. A grant from the National Institute of Child Health & Human Development supported the study.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth